Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

TRACERx Consortium

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Abstract

Patient-derived xenograft (PDX) models are widely used in cancer research. To investigate the genomic fidelity of non-small cell lung cancer PDX models, we established 48 PDX models from 22 patients enrolled in the TRACERx study. Multi-region tumor sampling increased successful PDX engraftment and most models were histologically similar to their parent tumor. Whole-exome sequencing enabled comparison of tumors and PDX models and we provide an adapted mouse reference genome for improved removal of NOD scid gamma (NSG) mouse-derived reads from sequencing data. PDX model establishment caused a genomic bottleneck, with models often representing a single tumor subclone. While distinct tumor subclones were represented in independent models from the same tumor, individual PDX models did not fully recapitulate intratumor heterogeneity. On-going genomic evolution in mice contributed modestly to the genomic distance between tumors and PDX models. Our study highlights the importance of considering primary tumor heterogeneity when using PDX models and emphasizes the benefit of comprehensive tumor sampling.

Original languageEnglish
Article number4653
JournalNature Communications
Volume15
Issue1
ISSN2041-1723
DOIs
Publication statusPublished - Dec 2024

Fingerprint

Dive into the research topics of 'Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models'. Together they form a unique fingerprint.

Cite this